TaiMed Biologics (Taiwan) Price on October 11, 2023
4147 Stock | TWD 84.30 2.30 2.80% |
If you're considering investing in TaiMed Stock, it is important to understand the factors that can impact its price. As of today, the current price of TaiMed Biologics stands at 84.30, as last reported on the 30th of November, with the highest price reaching 84.90 and the lowest price hitting 81.40 during the day. TaiMed Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0015, which indicates the firm had a -0.0015% return per unit of risk over the last 3 months. TaiMed Biologics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TaiMed Biologics' Semi Deviation of 1.36, coefficient of variation of 6783.64, and Risk Adjusted Performance of 0.0171 to confirm the risk estimate we provide.
TaiMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
TaiMed |
Sharpe Ratio = -0.0015
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 4147 |
Estimated Market Risk
1.82 actual daily | 16 84% of assets are more volatile |
Expected Return
0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TaiMed Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TaiMed Biologics by adding TaiMed Biologics to a well-diversified portfolio.
TaiMed Biologics Valuation on October 11, 2023
It is possible to determine the worth of TaiMed Biologics on a given historical date. On October 11, 2023 TaiMed was worth 88.9 at the beginning of the trading date compared to the closed value of 86.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TaiMed Biologics stock. Still, in general, we apply an absolute valuation method to find TaiMed Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TaiMed Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TaiMed Biologics' related companies.
Open | High | Low | Close | Volume | |
86.90 | 88.90 | 86.50 | 87.80 | 1,177,000 | |
10/11/2023 | 88.90 | 88.90 | 86.30 | 86.30 | 1,035,000 |
87.00 | 87.40 | 86.10 | 87.00 | 404,000 |
Backtest TaiMed Biologics | | | TaiMed Biologics History | | | TaiMed Biologics Valuation | Previous | Next |
TaiMed Biologics Trading Date Momentum on October 11, 2023
On October 12 2023 TaiMed Biologics was traded for 87.00 at the closing time. The highest price during the trading period was 87.40 and the lowest recorded bid was listed for 86.10 . The volume for the day was 404 K. This history from October 12, 2023 contributed to the next trading day price increase. The daily price change to the next closing price was 0.81% . The trading price change to the current price is 4.87% . |
TaiMed Biologics Fundamentals Correlations and Trends
By evaluating TaiMed Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TaiMed Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TaiMed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TaiMed Biologics Stock history
TaiMed Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TaiMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TaiMed Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TaiMed Biologics stock prices may prove useful in developing a viable investing in TaiMed Biologics
TaiMed Biologics Inc., a biotechnology company, develops health-care products. The company was founded in 2007 and is based in Taipei City, Taiwan. TAIMED BIOLOGICS operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
TaiMed Biologics Stock Technical Analysis
TaiMed Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TaiMed Biologics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
TaiMed Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
TaiMed Biologics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how TaiMed Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TaiMed Biologics shares will generate the highest return on investment. By undertsting and applying TaiMed Biologics stock market strength indicators, traders can identify TaiMed Biologics entry and exit signals to maximize returns
TaiMed Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TaiMed Biologics' price direction in advance. Along with the technical and fundamental analysis of TaiMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TaiMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0171 | |||
Jensen Alpha | (0) | |||
Total Risk Alpha | (0.29) | |||
Sortino Ratio | (0.07) | |||
Treynor Ratio | 0.1134 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.